Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 6/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.54 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.54 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.51 |
| ▸ | MME | P08473 | 4/20 | 0.50 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.50 |
| ▸ | CPA1 | P15085 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | CDC25B | P30305 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30081065 | 1.00 | ACE (0.56) | ACEFOLH1NAALAD2ITGB3ITGA2B | |
| SCHEMBL4147877 | 0.93 | NAALAD2 (0.61) | ACEFOLH1NAALAD2ITGB3ITGA2B | |
| SCHEMBL4147882 | 0.93 | NAALAD2 (0.61) | ACEFOLH1NAALAD2ITGB3ITGA2B | |
| SCHEMBL4147413 | 0.89 | ITGB3 (0.62) | ACEFOLH1NAALAD2ITGB3ITGA2B | |
| SCHEMBL4147927 | 0.89 | ITGB3 (0.62) | ACEFOLH1NAALAD2ITGB3ITGA2B | |
| SCHEMBL4147924 | 0.89 | ITGB3 (0.62) | ACEFOLH1NAALAD2ITGB3ITGA2B | |
| SCHEMBL4147417 | 0.89 | ITGB3 (0.62) | ACEFOLH1NAALAD2ITGB3ITGA2B | |
| SCHEMBL29227594 | 0.88 | ACE (0.58) | ACEFOLH1ITGB3ITGA2BMME | |
| SCHEMBL30915225 | 0.88 | ACE (0.58) | ACEFOLH1ITGB3ITGA2BMME | |
| SCHEMBL30845347 | 0.86 | NAALAD2 (0.54) | ACEFOLH1NAALAD2ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117616034-A | Composition for preventing or treating inflammatory bowel disease containing novel compounds | 安尼根有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-115362165-A | Antidiabetic and antiobesity composition comprising novel compounds | 安尼根有限公司 | 2022-11-18 | — | — | CN | disclosed |